PressWatch Posted August 27, 2010 Posted August 27, 2010 From PresswatchHere's some good news about the use of those strange things Monoclonal Antibodies which seem to be the focus of some attention. Its merely a lab based study though its encouraging that tigatuzumab (DR5) seems to making an impact on Pancreatic Cancer by helping to control re-growth of cells ( cancer stem cell control) http://www.ncbi.nlm.nih.gov/pubmed/20660600?dopt=AbstractThe work seems to be based in John Hopkins (USA) though also involves Spannish contributions which is also encouraging.Presswatch.
Recommended Posts